Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Longitudinal Biomarker Study in Pancreatic Neuroendocrine Tumours

NCT03130205 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT03130205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03130205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Longitudinal Biomarker Study in Pancreatic Neuroendocrine Tumours
Lead sponsor
Uppsala University
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2017
Completion date
January 1, 2022
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroendocrine tumors